References
- Oudejans C, Van Dijk M, Oostercamp M, Augusta L, Marinus B A. Genetics of preeclampsia: paradigm shifts. Hum Genetics 2007; 120: 607–612
- Sibai B M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103: 981–991
- Poort S R, Rosendaal F R, Reitsma P H, Bertina. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703
- Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen M B. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 1999; 61: 265–267
- Benedetto C, Marozio L, Salton L, Maula V, Chieppa G, Massobrio M. Factor V Leiden and factor II G20210A' in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand 2002; 81: 1095–1100
- Schlembach D, Beinder E, Zingsem J, Wunsiedler U, Beckmann M, Fisher T. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci 2003; 105: 279–285
- Moessmer G, Muller B, Koelben M, Schmitt M, Schneider K, Artmann A. HELLP syndrome with fetal growth retardation in a woman homozygous for the prothrombin gene variant 20210A. Thromb Haemost 2005; 93: 787–788
- Kist W J, Janssen N G, Kalk J J, Hague W M, Dekker G A, de Vries J I. Thrombophilias and adverse pregnancy outcome – A confounded problem!. Thromb Haemost 2008; 99: 77–85